HLA DR antigens in childhood acute lymphoblastic leukaemia long survival. 1982

M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D015805 HLA-DR5 Antigen A broad-specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*11 and DRB1*12 alleles. HLA-DR5,Antigen, HLA-DR5,HLA DR5 Antigen

Related Publications

M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
March 1987, British journal of cancer,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
February 1981, British journal of haematology,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
November 1994, Journal of clinical pathology,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
July 1999, Blood,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
August 2016, British journal of haematology,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
January 1997, European journal of cancer (Oxford, England : 1990),
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
March 1975, British medical journal,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
March 1975, British medical journal,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
January 1975, British medical journal,
M De Bruyere, and G Cornu, and J Ninane, and D Latinne, and A M Lebacq, and G Sokal
March 1996, British journal of cancer,
Copied contents to your clipboard!